| Name | Title | Contact Details |
|---|---|---|
Ashwin Altekar |
Vice President of Information Security | Profile |
Johnson Mathers Health Care Inc is a Carlisle, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Green Organic Dutchman Ltd. produces farm grown, high quality organic medical cannabis in small batches using craft growing, all natural and organic principles. The Green Organic Dutchman Ltd. is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical marijuana. The Green Organic Dutchman carries out its principal activities producing marijuana from its facilities located on a 100-acre farm in Ancaster, Ontario, pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
Life Support Technologies Group is a Valhalla, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As the region`s leading provider of health care, Columbus Regional Health has touched the lives of most of the children and adults in this region through its comprehensive network of services. Located in the West Georgia city of Columbus, Columbus Regional Health was established in 1986 as a not-for-profit health services organization, but its roots can be traced back to 1836 when the local hospital was a small wooden building on the banks of the Chattahoochee River.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.